$165.14
3.22% today
NYSE, Apr 04, 08:44 pm CET
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Stock price

$170.63
-6.32 3.57% 1M
+18.50 12.16% 6M
+19.77 13.10% YTD
+38.24 28.88% 1Y
+36.09 26.82% 3Y
+97.29 132.66% 5Y
+94.83 125.11% 10Y
NYSE, Closing price Thu, Apr 03 2025
+2.67 1.59%
ISIN
US74834L1008
Symbol
DGX
Sector

Key metrics

Market capitalization $18.94b
Enterprise Value $25.59b
P/E (TTM) P/E ratio 22.17
EV/FCF (TTM) EV/FCF 28.15
EV/Sales (TTM) EV/Sales 2.59
P/S ratio (TTM) P/S ratio 1.92
P/B ratio (TTM) P/B ratio 2.79
Dividend yield 1.76%
Last dividend (FY24) $3.00
Revenue growth (TTM) Revenue growth 6.70%
Revenue (TTM) Revenue $9.87b
EBIT (operating result TTM) EBIT $1.41b
Free Cash Flow (TTM) Free Cash Flow $909.00m
Cash position $549.00m
EPS (TTM) EPS $7.70
P/E forward 19.98
P/S forward 1.76
EV/Sales forward 2.37
Short interest 2.84%
Show more

Is Quest Diagnostics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Quest Diagnostics Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Quest Diagnostics forecast:

10x Buy
45%
12x Hold
55%

Analyst Opinions

22 Analysts have issued a Quest Diagnostics forecast:

Buy
45%
Hold
55%

Financial data from Quest Diagnostics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
9,872 9,872
7% 7%
100%
- Direct Costs 6,726 6,726
7% 7%
68%
3,146 3,146
6% 6%
32%
- Selling and Administrative Expenses 1,240 1,240
6% 6%
13%
- Research and Development Expense - -
-
-
1,906 1,906
6% 6%
19%
- Depreciation and Amortization 493 493
12% 12%
5%
EBIT (Operating Income) EBIT 1,413 1,413
3% 3%
14%
Net Profit 866 866
2% 2%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Quest Diagnostics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quest Diagnostics Stock News

Positive
Seeking Alpha
about 2 hours ago
8 Upcoming Dividend Increases During Volatile Times
Neutral
PRNewsWire
2 days ago
Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to screening by enabling discreet self-collection Quest also plans to make self-collection option available at its 2,000 patient service centers in the United States early next month, expanding access to s...
Neutral
PRNewsWire
3 days ago
SECAUCUS, N.J. , April 1, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2025 financial results on Tuesday, April 22, 2025, before the market opens.
More Quest Diagnostics News

Company Profile

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Head office United States
CEO James Davis
Employees 56,000
Founded 1967
Website www.questdiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today